Showing results (381-390 of 536) with videos related to

Sort By:
Pageof 54
The Biochemical Journal|April 1, 1991
Distinct forms of cytochrome P-450 are responsible for 6 beta-hydroxylation of bile acids and of neutral steroidsP Zimniak, E J Holsztynska, A Radominska, et al.
Molecular Pharmacology|November 1, 1987
Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylationsD J Waxman, D P Lapenson, S S Park, et al.
Archives of Biochemistry and Biophysics|May 1, 1992
Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms?M A Correia, K Yao, S A Wrighton, et al.
Blood|September 1, 1985
Purification and characterization of the human neutrophil NADH-cytochrome b5 reductaseA I Tauber, J Wright, F K Higson, et al.
Urological Research|September 30, 2000
Epithelial mucin expression in bladder cancer: correlation with pathological and clinical parametersK N Syrigos, D M Deonarain, A Karayiannakis, et al.
Gastroenterology|November 1, 1988
Antibodies to liver/kidney microsome1 in chronic active hepatitis recognize specific forms of hepatic cytochrome P-450D J Waxman, D P Lapenson, M Krishnan, et al.
Toxicology and Applied Pharmacology|July 20, 2002
Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathwaysYuan Chun Zhou, Helen W Davey, Michael J McLachlan, et al.
Oncogene|June 6, 2006
Regulation of prostate cell growth and morphogenesis by Dickkopf-3Y Kawano, M Kitaoka, Y Hamada, et al.
QJM : Monthly Journal of the Association of Physicians|March 21, 2009
Voodoo dolls and the cancer patient: patients do trust their doctorsT Newsom-Davis, L Kenny, I Al-Shakarchi, et al.
Oncogene|December 20, 2011
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgensD A Dart, G N Brooke, A Sita-Lumsden, et al.
Pageof 54